T Cell Receptor Technology (TCRs) - Juno Therapeutics | Breakthrough Immunotherapies for Cancer
T Cell Receptors (TCRs) Our high-affinity TCR technology has the potential to recognize proteins expressed inside cancer cells or proteins on the cell surface, which may allow us to target a broad range of tumors. The gene sequence we introduce into T cel...